First, we evaluated liver injury markers in plasma (ALT and GGT) and hepatic tissue (lipid peroxidation), HCC markers in liver biopsies (Afp and Gpc3 expression), and morphometric analysis in both groups (Figure 3A,B and Supplementary Table S5). This evidence concerns the gene GPC3 and hepatocellular carcinoma.